Suppr超能文献

TNM 分期和肿瘤坏死对肾细胞癌的预后价值。

Prognostic value of TNM stage and tumor necrosis for renal cell carcinoma.

机构信息

Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

出版信息

Kaohsiung J Med Sci. 2011 Feb;27(2):59-63. doi: 10.1016/j.kjms.2010.12.004. Epub 2011 Feb 5.

Abstract

Our objective was to assess the value of tumor necrosis and other factors for predicting the outcome of renal cell carcinoma (RCC). Our study comprised 328 RCC patients who were surgically treated at this hospital between 2001 and 2006. The five-year survival data was analyzed using a Kaplan-Meier statistical analysis. The prognostic factors were evaluated with a univariate analysis using a log-rank test and multivariate analysis using the Cox proportional hazards regression method. The mean follow-up period for these patients was 46.5 months (median 45.2 months). The univariate analysis revealed that age, tumor stage, TNM stage, grade, tumor necrosis, and histological type were statistically significant prognostic factors. The multivariate analysis showed that the TNM stage and tumor necrosis were the most important predictive factors in the patients' overall survival. In the TNM stage with and without tumor necrosis, the five-year overall survival rates in stages I+II were 80.5% and 89.2%, respectively (p=0.115), where as the five-year survival rates in stages III+IV were 32.7% and 84.0%, respectively (p<0.001). Collectively, our present data revealed that tumor necrosis was an important predictive factor for survival in advanced stage RCC. In conclusion, both the TNM stage and tumor necrosis provided the most important prognostic factors of survival in RCC. Tumor necrosis proved to be a poor prognostic factor in advanced RCCs.

摘要

我们的目的是评估肿瘤坏死和其他因素对于预测肾细胞癌(RCC)患者预后的价值。我们的研究包括了 2001 年至 2006 年期间在我院接受手术治疗的 328 例 RCC 患者。采用 Kaplan-Meier 统计分析对患者的 5 年生存数据进行分析。采用对数秩检验的单因素分析和 Cox 比例风险回归方法的多因素分析来评估预后因素。这些患者的平均随访时间为 46.5 个月(中位数 45.2 个月)。单因素分析显示,年龄、肿瘤分期、TNM 分期、分级、肿瘤坏死和组织学类型是统计学上显著的预后因素。多因素分析显示,TNM 分期和肿瘤坏死是患者总生存的最重要的预测因素。在有和没有肿瘤坏死的 TNM 分期中,I+II 期的 5 年总生存率分别为 80.5%和 89.2%(p=0.115),而 III+IV 期的 5 年生存率分别为 32.7%和 84.0%(p<0.001)。综上所述,我们的数据表明肿瘤坏死是晚期 RCC 患者生存的重要预测因素。总之,TNM 分期和肿瘤坏死为 RCC 患者的生存提供了最重要的预后因素。肿瘤坏死是晚期 RCC 预后不良的一个指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验